Requirements for Earning Credit and Method of Participation
Estimated Time to Complete Activity
In accordance with the ACCME’s Accreditation Criteria, the Society of Surgical Oncology must ensure that anyone in position to control the content of this educational activity has disclosed all financial relationships with a commercial interest. All educational planners, authors, reviewers, and other individuals in a position to control or influence the content of this activity were required to disclose all financial relationships with any commercial interest that have occurred within the past 12 months. This includes the disclosure of financial relationships of a spouse or partner. The ACCME considers financial relationships to create conflicts of interest when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The ACCME defines a commercial interest as “any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.” ACCME does not consider providers of clinical service directly to patients to be commercial interests.
The ACCME also requires that the Society of Surgical Oncology resolve any reported conflict of interest and ensure the educational content of this activity is vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.
All identified conflicts of interests have been resolved.
Authors
Yun Song MD, Richard J. Straker MD, Xiaowei Xu MD PhD, Phyllis A. Gimotty PhD, Alexander C. Huang MD, Ravi K. Amaravadi MD, Lynn M. Schuchter MD, Giorgos C. Karakousis MD
David Elder: Myriad Genetics -- Consultant
Tara Mitchell: Merck -- Advisory Board; BMS -- Advisory Board; Array -- Advisory Board
Peer Reviewers
Reviewer A has disclosed no conflicts of interest.
Reviewer B: Regeneron: Advisory Board
Reviewer names have been withheld for reasons of confidentiality, in keeping with the Annals of Surgical Oncology blind review policy and process for manuscript submission and acceptance.
Planners, Reviewers, and Staff
Douglas Tyler, MD, Section Editor, Annals of Surgical Oncology, has disclosed no conflicts of interest.
Adam Berger, MD, Disease Site Work Group Planner: Castle Biosciences: Advisory Board, Speaker Honorarium, Research; Cardinal Health -- Speaker Honorarium
Marissa Howard-McNatt, MD, Chair at the time of review, CME/CPD Committee, has disclosed no conflicts of interest.
Carolyn Nessim, MD, CME/CPD Committee Reviewer, has disclosed no conflicts of interest.
Deborah A. Whippen, Managing Editor, Annals of Surgical Oncology, has disclosed no financial relationships. (Planner/Staff)
Julie Smith, Editorial Manager, Annals of Surgical Oncology, has disclosed no financial relationships. (Planner/Staff)
Kelley Gazer, SSO Staff, Annals of Surgical Oncology, has disclosed no financial relationships. (Planner/Staff)
The primary purpose of the Society of Surgical Oncology's journal-CME is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.